International Union against Tuberculosis and Lung Disease (The Union), Mandalay, Myanmar.
International Union against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India.
PLoS One. 2018 Mar 29;13(3):e0194087. doi: 10.1371/journal.pone.0194087. eCollection 2018.
The Union in collaboration with national TB programme (NTP) started the community-based MDR-TB care (CBMDR-TBC) project in 33 townships of upper Myanmar to improve treatment initiation and treatment adherence. Patients with MDR-TB diagnosed/registered under NTP received support through the project staff, in addition to the routine domiciliary care provided by NTP staff. Each township had a project nurse exclusively for MDR-TB and 30 USD per month (max. for 4 months) were provided to the patient as a pre-treatment support.
To assess whether CBMDR-TBC project's support improved treatment initiation.
In this cohort study (involving record review) of all diagnosed MDR-TB between January 2015 and June 2016 in project townships, CBMDR-TBC status was categorized as "receiving support" if date of project initiation in patient's township was before the date of diagnosis and "not receiving support", if otherwise. Cox proportional hazards regression (censored on 31 Dec 2016) was done to identify predictors of treatment initiation.
Of 456 patients, 57% initiated treatment: 64% and 56% among patients "receiving support (n = 208)" and "not receiving support (n = 228)" respectively (CBMDR-TBC status was not known in 20 (4%) patients due to missing diagnosis dates). Among those initiated on treatment (n = 261), median (IQR) time to initiate treatment was 38 (20, 76) days: 31 (18, 50) among patients "receiving support" and 50 (26,101) among patients "not receiving support". After adjusting other potential confounders (age, sex, region, HIV, past history of TB treatment), patients "receiving support" had 80% higher chance of initiating treatment [aHR (0.95 CI): 1.8 (1.3, 2.3)] when compared to patients "not receiving support". In addition, age 15-54 years, previous history of TB and being HIV negative were independent predictors of treatment initiation.
Receiving support under CBMDR-TBC project improved treatment initiation: it not only improved the proportion initiated but also reduced time to treatment initiation. We also recommend improved tracking of all diagnosed patients as early as possible.
联盟与国家结核病规划(NTP)合作,在上缅甸的 33 个乡镇启动了基于社区的耐多药结核病护理(CBMDR-TBC)项目,以提高治疗启动率和治疗依从性。在 NTP 下诊断/登记的耐多药结核病患者除了接受 NTP 工作人员提供的常规家庭护理外,还接受该项目工作人员的支持。每个乡镇都有一名专门负责耐多药结核病的项目护士,每月为患者提供 30 美元(最多 4 个月)作为治疗前支持。
评估 CBMDR-TBC 项目的支持是否改善了治疗启动。
在本项涉及记录审查的队列研究(包括所有在项目乡镇 2015 年 1 月至 2016 年 6 月期间诊断的耐多药结核病患者)中,如果患者所在乡镇的项目启动日期早于诊断日期,则将 CBMDR-TBC 状况归类为“接受支持”,否则归类为“未接受支持”。对 Cox 比例风险回归(截止日期为 2016 年 12 月 31 日)进行分析,以确定治疗启动的预测因素。
在 456 名患者中,有 57%开始接受治疗:接受支持(n=208)的患者中有 64%,未接受支持(n=228)的患者中有 56%(由于缺少诊断日期,20 名(4%)患者的 CBMDR-TBC 状况未知)。在开始治疗的患者(n=261)中,开始治疗的中位(IQR)时间为 38(20,76)天:接受支持的患者为 31(18,50)天,未接受支持的患者为 50(26,101)天。在调整其他潜在混杂因素(年龄、性别、地区、HIV、既往结核病治疗史)后,与未接受支持的患者相比,接受支持的患者开始治疗的可能性高 80%[调整危险比(aHR)(95%CI):1.8(1.3,2.3)]。此外,年龄在 15-54 岁之间、既往有结核病史和 HIV 阴性是治疗启动的独立预测因素。
在 CBMDR-TBC 项目下接受支持提高了治疗启动率:不仅提高了开始治疗的比例,还缩短了开始治疗的时间。我们还建议尽早跟踪所有确诊患者。